U.S. flag

An official website of the United States government

NM_000488.4(SERPINC1):c.235C>A (p.Arg79Ser) AND Hereditary antithrombin deficiency

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
May 9, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000019631.29

Allele description [Variation Report for NM_000488.4(SERPINC1):c.235C>A (p.Arg79Ser)]

NM_000488.4(SERPINC1):c.235C>A (p.Arg79Ser)

Gene:
SERPINC1:serpin family C member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q25.1
Genomic location:
Preferred name:
NM_000488.4(SERPINC1):c.235C>A (p.Arg79Ser)
Other names:
R47S; NM_000488.4(SERPINC1):c.235C>A
HGVS:
  • NC_000001.11:g.173914726G>T
  • NG_012462.1:g.7653C>A
  • NM_000488.4:c.235C>AMANE SELECT
  • NM_001365052.2:c.91C>A
  • NM_001386302.1:c.235C>A
  • NM_001386303.1:c.316C>A
  • NM_001386304.1:c.235C>A
  • NM_001386305.1:c.235C>A
  • NM_001386306.1:c.235C>A
  • NP_000479.1:p.Arg79Ser
  • NP_001351981.1:p.Arg31Ser
  • NP_001373231.1:p.Arg79Ser
  • NP_001373232.1:p.Arg106Ser
  • NP_001373233.1:p.Arg79Ser
  • NP_001373234.1:p.Arg79Ser
  • NP_001373235.1:p.Arg79Ser
  • LRG_577:g.7653C>A
  • NC_000001.10:g.173883864G>T
  • P01008:p.Arg79Ser
Protein change:
R106S; ARG47SER
Links:
UniProtKB: P01008#VAR_007039; OMIM: 107300.0016; dbSNP: rs121909547
NCBI 1000 Genomes Browser:
rs121909547
Molecular consequence:
  • NM_000488.4:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001365052.2:c.91C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386302.1:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386303.1:c.316C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386304.1:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386305.1:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386306.1:c.235C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary antithrombin deficiency (AT3D)
Synonyms:
Antithrombin III deficiency; Thrombophilia due to antithrombin III deficiency; Reduced antithrombin III activity; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013144; MedGen: C0272375; OMIM: 613118; Human Phenotype Ontology: HP:0001976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000039929OMIM
no assertion criteria provided
Pathogenic
(Jun 18, 1990)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV005061624Clingen Thrombosis Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen ACMG Specifications SERPINC1 V1.0.0)
Likely Pathogenic
(May 9, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding.

Borg JY, Brennan SO, Carrell RW, George P, Perry DJ, Shaw J.

FEBS Lett. 1990 Jun 18;266(1-2):163-6.

PubMed [citation]
PMID:
2365065

Details of each submission

From OMIM, SCV000039929.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Borg et al. (1988) identified heterozygosity for an arg47-to-ser (R47S) substitution in the AT3 gene in a 40-year-old man who was admitted to hospital with a sudden myocardial infarction that lacked extensive coronary artery disease. His 13-year-old daughter displayed the same antithrombin abnormality. The variant, designated AT-III Rouen II, showed defective heparin and heparan sulfate activities. There was no definite family history of thrombosis.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Clingen Thrombosis Variant Curation Expert Panel, ClinGen, SCV005061624.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.235C>A variant in SEPRINC1 is a missense variant predicted to cause substitution of arginine by serine at amino acid 79 (p.Arg79Ser). This variant has been reported in one family with an abnormal crossed immunoelectrophoresis assay demonstrating decreased antithrombin function. (PS4_Supporting; PMID:3350974). This variant is absent from gnomAD v[2.1.1] (PM2_Supporting). This variant resides within a region, Arg79, of SERPINC1 that is defined as a critical functional domain that would impact heparin binding site residues by the ClinGen Thrombosis Variant Curation Expert Panel (PM1). Another missense variant c.236G>A (p.Arg79His) (ClinVarID:18014) in the same codon has been classified as pathogenic for hereditary antithrombin deficiency by the ClinGen Thrombosis Variant Curation Expert Panel (PM5). The computational predictor REVEL gives a score of 0.718, which is above the threshold of 0.6, evidence that correlates with impact to SERPINC1 function (PP3). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant hereditary antithrombin deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Thrombosis Variant Curation Expert Panel: PM1, PM5, PP3, PM2_Supporting, PS4_Supporting. (Required: ClinGen Thrombosis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SERPINC1 Version 1.0.0; date of approval)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024